Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| REC-7735 in Participants With Solid Tumors | neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT07819136 | |
| A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-08-20 | NCT06678659 | |
| Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP) | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, classic familial adenomatous polyposis, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-06-05 | NCT05552755 |